ZeptoMetrix® Launches New Women’s Health Molecular Quality Controls


Buffalo, NY, July 14, 2022 — ZeptoMetrix, an Antylia Scientific company, today launches two new vaginal molecular quality controls, NATVPOS-6C Vaginal Positive Control and NATVNEG-6C Vaginal Negative Control, for in vitro diagnostic use. They are in stock and available for shipment. These latest third-party molecular controls provide additional confidence in the quality and reliability of clinical laboratory testing.

“We are committed to women’s health and helping clinicians and laboratories elevate their patient care,” said Evangeline Gonzalez, Vice President/General Manager of ZeptoMetrix.

The launch of these new women’s health controls comes at a time when laboratories around the world are starting to move beyond COVID testing. ZeptoMetrix offers a variety of controls and panels for women’s health and sexually transmitted infections (STIs) for routine QC testing. The extensive ZeptoMetrix product offering helps labs adapt new tests by providing easy-to-use, refrigerated, whole organism controls designed to quickly and safely assure that testing instruments are providing accurate results.

Gonzalez concluded, “As laboratories expand their testing, ZeptoMetrix is ready to help with our broad portfolio of Women’s Health, Gastrointestinal, Healthcare-Associated Infections and our combination Flu/RSV/SARS-COVID controls.”

Visit www.zeptometrix.com for more information on the new Trichomonas vaginalis (TV) and associated Women’s Health products.